Minerva Neurosciences NERV Stock
Minerva Neurosciences Price Chart
Minerva Neurosciences NERV Financial and Trading Overview
| Minerva Neurosciences stock price | 2.5 USD |
| Previous Close | 7.52 USD |
| Open | 7.52 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 2200 |
| Day's Range | 7.03 - 7.52 USD |
| 52 Week Range | 1.26 - 15.27 USD |
| Volume | 66.38K USD |
| Avg. Volume | 199.88K USD |
| Market Cap | 40.76M USD |
| Beta (5Y Monthly) | 0.010563 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.61 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8 USD |
NERV Valuation Measures
| Enterprise Value | 4.78M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.5037594 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Minerva Neurosciences Stock Price History
| Beta (5Y Monthly) | 0.010563 |
| 52-Week Change | 131.64% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 15.27 USD |
| 52 Week Low | 1.26 USD |
| 50-Day Moving Average | 5.04 USD |
| 200-Day Moving Average | 4.39 USD |
NERV Share Statistics
| Avg. Volume (3 month) | 199.88K USD |
| Avg. Daily Volume (10-Days) | 90.4K USD |
| Shares Outstanding | 5.57M |
| Float | 5.28M |
| Short Ratio | 0.31 |
| % Held by Insiders | 3.42% |
| % Held by Institutions | 33.16% |
| Shares Short | 134.99K |
| Short % of Float | 3.23% |
| Short % of Shares Outstanding | 2.41% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.10% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -29314660 USD |
| Diluted EPS (ttm) | -6.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 35.98M USD |
| Total Cash Per Share (mrq) | 6.46 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 14.66 |
| Book Value Per Share (mrq) | -4.984 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18952180 USD |
| Levered Free Cash Flow (ttm) | -16051433 USD |
Profile of Minerva Neurosciences
| Country | United States |
| State | MA |
| City | Burlington |
| Address | 1500 District Avenue |
| ZIP | 01803 |
| Phone | 617 600 7373 |
| Website | https://www.minervaneurosciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Q&A For Minerva Neurosciences Stock
What is a current NERV stock price?
Minerva Neurosciences NERV stock price today per share is 2.5 USD.
How to purchase Minerva Neurosciences stock?
You can buy NERV shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Minerva Neurosciences?
The stock symbol or ticker of Minerva Neurosciences is NERV.
Which industry does the Minerva Neurosciences company belong to?
The Minerva Neurosciences industry is Biotechnology.
How many shares does Minerva Neurosciences have in circulation?
The max supply of Minerva Neurosciences shares is 6.99M.
What is Minerva Neurosciences Price to Earnings Ratio (PE Ratio)?
Minerva Neurosciences PE Ratio is now.
What was Minerva Neurosciences earnings per share over the trailing 12 months (TTM)?
Minerva Neurosciences EPS is -4.61 USD over the trailing 12 months.
Which sector does the Minerva Neurosciences company belong to?
The Minerva Neurosciences sector is Healthcare.
Minerva Neurosciences NERV included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}